Sort
82,697 grants matching “vaccine development”
Mapping Immune Responses to CMV in Renal Transplant Recipients
$1,566,001Elaine F Reed · University Of California Los Angeles · U19 · FY2019 · AI
HIV LCMV vaccines
$1,565,994Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2011 · AI
NCI-Frederick Support and Technical Services
$1,565,760Douglas R. Lowy · Office Of The Director, Nci · ZIC · FY2011 · CA
HIV Research for Prevention 2016: Vaccine, Microbicide and ARV-based Prevention Science (HIV R4P)
$1,565,429Thomas Hope · Northwestern University At Chicago · R13 · FY2016 · AI
Comprehensive SDSU/UCSD Cancer Center Partnership 1 of 2
$1,564,875Elizabeth A Klonoff · San Diego State University · U54 · FY2011 · CA
Manufacturing and Regulatory Support of Ad/MVA and Ad/Protein HIV-1 Vaccines
$1,564,863Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2015 · AI
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
$1,564,718Martin Cheever · Fred Hutchinson Cancer Research Center · U01 · FY2011 · CA
Resource for Molecular Imaging Agents in Precision Medicine
$1,563,638Martin G Pomper · Johns Hopkins University · P41 · FY2017 · EB
Natural History of HPV Infection to Neoplasia
$1,562,921Anna-Barbara None Moscicki · University Of California, San Francisco · R37 · FY2011 · CA
Structure-based design of novel Lassa virus glycoproteins for vaccine development
$1,562,780Robert F Garry · Tulane University Of Louisiana · R01 · FY2017 · AI
Vaccines for fentanyl and its derivatives: A strategy to reduce illicit use and overdose
$1,562,143Marco Pravetoni · University Of Minnesota · UG3 · FY2019 · DA
Vanderbilt HIV Clinical Trials Unit
$1,562,084Richard T D'aquila · Vanderbilt University · U01 · FY2010 · AI
A Dynamic COVID-19 Community-Engaged Testing Strategy in Alabama (COVID COMET AL)
$1,562,049Renee A. Heffron · University Of Alabama At Birmingham · P30 · FY2022 · AI
University of Cincinnati AIDS Clinical Trials Unit- UC ACTU
$1,562,020Judith E Feinberg · University Of Cincinnati · U01 · FY2007 · AI
University of Washington Vaccine and Treatment Evaluation Unit
$1,561,928Anna Wald · University Of Washington · UM1 · FY2022 · AI
Antigen Processing And Presentation In The Intestine
$1,561,593Brian Kelsall · Niaid Extramural Activities · Z01 · FY2007 · AI
Drivers of individual variation in influenza vaccine response and protection from infection
$1,561,514Sarah Cobey · University Of Chicago · R01 · FY2022 · AI
DNA Vaccines
$1,560,936George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Interplay of B cells and HIV Leading to Broad Neutralizing Antibody Responses
$1,560,717Pascal Poignard · International Aids Vaccine Initiative · U19 · FY2010 · AI
The Pathogenesis, Diagnosis, And Treatment of Systemic Mast Cell Disorders
$1,560,543Dean D Metcalfe · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
University of Cincinnati AIDS Clinical Trials Unit- UC ACTU
$1,560,131Carl J Fichtenbaum · University Of Cincinnati · UM1 · FY2013 · AI
Building on the success of the adoptive immunotherapy of cancer
$1,560,072Nicholas Restifo · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
AIDS CLINICAL TRIALS UNIT
$1,559,846Stanford University · U01 · FY2005 · AI
Population-based Approach to Malaria Research and Control
$1,559,554Donald J. Krogstad · Tulane University Of Louisiana · U19 · FY2015 · AI
Stanford/UNC Biomimetic U19 Research Center
$1,559,276Calvin J Kuo · Stanford University · U19 · FY2021 · AI